Corvus Capital Ltd. 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-19 4:59 pm Sale | 2024-03-26 | 13D | Conduit Pharmaceuticals Inc. CDT | Corvus Capital Ltd. | 302,927 31.560% | -153,011 (-33.56%) | Filing |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13D | Conduit Pharmaceuticals Inc. CDT | Corvus Capital Ltd. | 455,938 62.960% | 455,938 (New Position) | Filing |